Genomic and Transcriptomic Analysis of Colistin-Susceptible and Colistin-Resistant Isolates Identify Two-Component System EvgS/EvgA Associated with Colistin Resistance in Escherichia coli
Fen Wan,Linna Xu,Zhi Ruan,Qixia Luo
DOI: https://doi.org/10.2147/IDR.S316963
2021-06-28
Infection and Drug Resistance
Abstract:Fen Wan, 1 Linna Xu, 1 Zhi Ruan, 2 Qixia Luo 3 1 School of Laboratory Medicine, Hangzhou Medical College, Hangzhou, Zhejiang, People's Republic of China; 2 Department of Clinical Laboratory, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, 310016, People's Republic of China; 3 State Key Laboratory for Diagnosis and Treatment of Infectious Diseases; Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital of Medical School, College of medicine, Zhejiang University, Hangzhou, 310003, People's Republic of China Correspondence: Qixia Luo State Key Laboratory for Diagnosis and Treatment of Infectious Diseases; Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital of Medical School, College of medicine, Zhejiang University, 79 Qingchun Road, Hangzhou, 310003, People's Republic of China Email Zhi Ruan Department of Clinical Laboratory, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, 3 East Qingchun Road, Hangzhou, 310016, People's Republic of China Email Purpose: Colistin is one of the last-resort antimicrobial agents that combat the increasing threat of multi-drug resistant (MDR) gram-negative bacteria. Based on the known mechanism of colistin resistance which contributes to chromosomal mutations involved in the synthesis and modification of lipopolysaccharide (LPS), we explored the regulatory genes mediate colistin resistance, by whole genome sequencing and transcriptome analysis. Materials and Methods: In this study, a colistin-resistant (Col r ) strain Escherichia coli ATCC 25922-R was generated from colistin-sensible (Col s ) strain E. coli ATCC 25922 by colistin induction. We compared the genome and transcriptome sequencing result from Col s and Col r strain. MALDI-TOF mass spectrometry was used to detect LPS. Results: Genomic analysis and complementation experiment demonstrated the PmrB amino acid substitution in ATCC 25922-R (L14R) conferred the colistin resistance phenotype. Results of RNA sequencing (RNA-Seq) and comparative transcriptome analysis indicated that the two-component system EvgS/EvgA is highly involved in the global regulation of colistin resistance. Conclusion: This study demonstrated that PmrB L14R amino acid substitution resulted in colistin resistance, and two-component system EvgS/EvgA might participate in colistin resistance in E. coli . Keywords: colistin resistance, Escherichia coli , PmrAB, EvgS/EvgA Multi-drug resistant (MDR) bacteria are a global healthcare concern responsible for increased morbidity and mortality, hospitalization, and huge financial loss. In order to combat increasing rise of MDR bacteria, various therapies have been developed to inhibit MDR bacterial infection including traditional antibiotics, phage therapies, monoclonal antibodies (mAbs), immune stimulation, vaccines and antimicrobial peptides. 1–4 But there are very few phages available to doctors and the number of currently licensed mAbs is limited in clinical practice. In terms of traditional antibiotics, only a handful of last-line antibiotics, such as colistin and tigecycline, are proven to be effective in MDR bacteria treatment. 5 Colistin (polymyxin E) is a decades-old antimicrobial agent, intensively used in veterinary medicine and animal husbandry. 6 In humans, the global spread of MDR Gram-negative bacteria with limited therapeutic options has resulted in the return of colistin use regardless of its documented nephrotoxicity. 7 Colistin is a cationic polypeptide that disrupts membrane integrity through displacement of cations like Mg 2+ and Ca 2+ in the outer membrane, leading to cell lysis. 5 , 8 Two widely accepted mechanisms of colistin resistance that have been described in Gram-negative bacteria are as follows: chromosomal mutations in genes involved in the synthesis and modification of lipopolysaccharide (LPS) and the acquisition of mobile colistin resistance ( mcr ) genes encoding phosphoethanolamine transferases, resulting in a more cationic charged LPS or loss of LPS that confers reduced susceptibility to colistin. 8 The critical step of colistin resistance is the modification of negatively charged lipid A, the endotoxic component, via diverse routes, particularly through derivation of lipid A phosphate moieties w -Abstract Truncated-
pharmacology & pharmacy,infectious diseases